Gary Landucci Phones & Addresses
-
1689 Samar Dr, Costa Mesa, CA 92626 (714) 545-2211 (714) 545-7008
-
216 Saybrook Ct, Costa Mesa, CA 92627 (949) 642-7004
-
Minneapolis, MN
-
Shoreview, MN
-
Orange, CA
-
1689 Samar Dr, Costa Mesa, CA 92626 (714) 404-9254
Work
Position:
Executive, Administrative, and Managerial Occupations
Education
Degree:
Associate degree or higher
Publications
Us Patents
Lymphokine Activated Effector Cells For Antibody-Dependent Cellular Cytotoxicity (Adcc) Treatment Of Cancer And Other Diseases
View pageUS Patent:
53086260, May 3, 1994
Filed:
Dec 13, 1991
Appl. No.:
7/808958
Inventors:
Gary R. Landucci - Costa Mesa CA
Toni N. Mariani - Minneapolis MN
Toni N. Mariani - Minneapolis MN
International Classification:
A61K 4505
A61K 39395
A61K 3766
A61K 3514
A61K 39395
A61K 3766
A61K 3514
US Classification:
424 93V
Abstract:
This invention relates to processes and compositions for the immunotherapeutic treatment of cancer and non-malignant tumors. More particularly, this invention relates to processes and compositions for enhancing the body's immune response by increasing the cytotoxic activity of cells which mediate antibody dependent cellular cytotoxicity. Cells which are characterized by increased cytotoxic activity, as a result of the process of this invention, are useful in methods and compositions for the treatment of various types of cancer and non-malignant tumors.
Lymphokine Activated Effector Cells For Antibody-Dependent Cellular Cytotoxicity (Adcc) Treatment Of Cancer And Other Diseases
View pageUS Patent:
57560978, May 26, 1998
Filed:
May 2, 1994
Appl. No.:
8/237595
Inventors:
Gary R. Landucci - Costa Mesa CA
Toni N. Mariani - Minneapolis MN
Toni N. Mariani - Minneapolis MN
International Classification:
A61K 4505
A61K 39395
A61K 3820
A61K 3821
A61K 39395
A61K 3820
A61K 3821
US Classification:
4241551
Abstract:
This invention relates to processes and compositions for the immunotherapeutic treatment of cancer and non-malignant tumors. More particularly, this invention relates to processes and compositions for enhancing the body's immune response by increasing the cytotoxic activity of cells which mediate antibody dependent cellular cytotoxicity. Cells which are characterized by increased cytotoxic activity, as a result of the process of this invention, are useful in methods and compositions for the treatment of various types of cancer and non-malignant tumors.